DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 32.00
-0.15 (-0.47%)
Apr 20, 2026, 1:24 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 1.88 billion as of April 20, 2026. Its market cap has decreased by -18.78% in one year.
Market Cap
1.88B
Enterprise Value
1.39B
Revenue
868.84M
Ranking
n/a
PE Ratio
20.78
Stock Price
32.00
Market Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 1.88B, an increase of 340.99%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.88B | -8.31% |
| Dec 31, 2025 | 2.05B | -8.76% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| TaiRx | 1.99B |
| TSH Biopharm Corporation | 1.95B |
| Medical Imaging | 1.93B |
| OK Biotech | 1.89B |